Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.900
+0.050 (1.75%)
At close: Apr 28, 2026, 4:00 PM EDT
2.810
-0.090 (-3.10%)
After-hours: Apr 28, 2026, 6:17 PM EDT
ACTU's stock price has decreased by -67.6% in the past year and price targets may not have had time to catch up.

Actuate Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$17.50
Upside
+503.45%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +417.24% Apr 22, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$20$15
Strong Buy Maintains $20$15 +417.24% Apr 13, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong Buy Reiterates $20 +589.66% Nov 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong Buy Reiterates $20 +589.66% Sep 23, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$20
Strong Buy Initiates $20 +589.66% Aug 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong Buy Reiterates $20 +589.66% Aug 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$20
Strong Buy Initiates $20 +589.66% Mar 17, 2025